title: Contribution of adrenergic mechanisms to glucose counterregulation in humans.
abstract: To assess the role of adrenergic mechanisms during prolonged hypoglycemia, eight normal subjects were studied on six occasions. In study 1, insulin was infused subcutaneously (15 mU.m-2.min-1 for 12 h), and plasma glucose concentration (PG) decreased from 89 +/- 2 to 50 +/- 1 mg/dl. In study 2 (insulin as in study 1 + propranolol and phentolamine + variable glucose to maintain PG as in study 1), the rate of hepatic glucose production (HGO, [3-3H]glucose) was approximately 30% lower after 1.5 h, and the rate of peripheral glucose utilization (GU) was approximately 15% greater after 5 h. To quantitate the effects of adrenergic mechanisms on glucose counterregulation, in a control study (study 3), glucoregulatory hormone secretion was blocked, and the hormones were reinfused to reproduce study 1. When alpha- and beta-blockade plus variable glucose were superimposed to study 3 (study 4), HGO was approximately 25% lower (after 2 h), and GU was approximately 10% greater (after 6 h) vs. study 3. When glucose was not infused to match PG of study 3 (study 5), severe hypoglycemia developed (PG at 7 h 36 +/- 2 vs. 62 +/- 3 mg/dl). Finally, when glucose was not infused during alpha- and beta-blockade of study 2 (study 6), PG was 49 +/- 3 mg/dl at 7 h vs. 65 +/- 3 mg/dl of the control study (study 1), despite greater secretion of glucagon, growth hormone, and cortisol. It is concluded that adrenergic mechanisms play a key counterregulatory role, even in the presence of appropriate responses of glucagon and that greater increases in glucagon (and other counterregulatory hormones) cannot compensate fully for absent contribution of adrenergic mechanisms to counterregulation.
authors.affiliation: Istituto di Patologia Medica, Università di Perugia, Italy.
authors.forename: P
authors.initials: P
authors.lastname: De Feo
authors.forename: G
authors.initials: G
authors.lastname: Perriello
authors.forename: E
authors.initials: E
authors.lastname: Torlone
authors.forename: C
authors.initials: C
authors.lastname: Fanelli
authors.forename: M M
authors.initials: MM
authors.lastname: Ventura
authors.forename: F
authors.initials: F
authors.lastname: Santeusanio
authors.forename: P
authors.initials: P
authors.lastname: Brunetti
authors.forename: J E
authors.initials: JE
authors.lastname: Gerich
authors.forename: G B
authors.initials: GB
authors.lastname: Bolli
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000097:blood*; D007515:Islets of Langerhans / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000378:metabolism; D011941:Receptors, Adrenergic / Q000378:metabolism*
chemical_list: D001786:Blood Glucose; D011941:Receptors, Adrenergic